> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Newtyn Reports Full Exit From Theravance Biopharma With Zero Shares Held
- URL: https://www.bullished.co/newtyn-reports-full-exit-from-theravance-biopharma-with-zero-shares-held-d18e4e06/
- Published: 2026-11-17T00:32:03.000Z
- Updated: 2026-11-17T00:32:03.000Z
- Description: The investment manager's ownership report covered both managed partnerships' holdings as of September 30, 2026.
- Author: Matteo Parrino
- Tags: SEC Filings, Industry: Not classified, Topic: Ownership & Activism

Newtyn Management, an investment manager for partnerships, reported [zero shares](https://www.sec.gov/Archives/edgar/data/0001569241/000149315226052319/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) of Theravance Biopharma in an SEC ownership amendment filed Monday. The full exit covered holdings as of September 30, 2026.

## Both Partnerships Held Zero

Newtyn TE Partners and Newtyn Partners, the partnerships managed by Newtyn Management, each held [zero ordinary shares](https://www.sec.gov/Archives/edgar/data/0001569241/000149315226052319/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) on September 30, 2026.

Newtyn's reported ownership stems from its role managing those partnerships. The manager reported a 0% stake in Theravance's ordinary shares and no voting power, either alone or shared with others.

## A Passive Position Ends

Newtyn classified the amendment as an exit disclosure. It also certified that the securities were bought and held without the purpose or effect of influencing or changing Theravance's control.

Learn

- [13D Filing Requirements And Deadline, Shown With Real Filings →](https://www.bullished.co/learn/13d-filing-requirements/)  
A Schedule 13D is required when you own more than 5% of a public company's voting shares. See the deadline, contents and real filings from this week.
- [13D Vs 13G: What Each 5% Stake Filing Means And How To Read One →](https://www.bullished.co/learn/13d-vs-13g/)  
13D vs 13G: both report stakes above 5%, but 13G is the short passive form and 13D explains intent. See real BlackRock and Pictet filings read in plain English.

### Sources

- [SCHEDULE 13G/A — Newtyn Management, LLC re: Theravance Biopharma, Inc.](https://www.sec.gov/Archives/edgar/data/0001569241/000149315226052319/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR